These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 22949875)

  • 21. Role of cytochrome c in α-synuclein radical formation: implications of α-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson's disease.
    Kumar A; Ganini D; Mason RP
    Mol Neurodegener; 2016 Nov; 11(1):70. PubMed ID: 27884192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease.
    Ebadi M; Sharma SK
    Antioxid Redox Signal; 2003 Jun; 5(3):319-35. PubMed ID: 12880486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease.
    Venkateshappa C; Harish G; Mythri RB; Mahadevan A; Bharath MM; Shankar SK
    Neurochem Res; 2012 Feb; 37(2):358-69. PubMed ID: 21971758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
    Shavali S; Combs CK; Ebadi M
    Neurochem Res; 2006 Jan; 31(1):85-94. PubMed ID: 16475001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired iron homeostasis in Parkinson's disease.
    Double KL; Gerlach M; Youdim MB; Riederer P
    J Neural Transm Suppl; 2000; (60):37-58. PubMed ID: 11205155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Free radicals and ailing proteins--the culprits behind Parkinson disease?].
    Smith R; Lotharius J; Brundin P
    Lakartidningen; 2003 Apr; 100(15):1324-6, 1329-30. PubMed ID: 12739402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free radicals in Parkinson's disease.
    Koutsilieri E; Scheller C; Grünblatt E; Nara K; Li J; Riederer P
    J Neurol; 2002 Sep; 249 Suppl 2():II1-5. PubMed ID: 12375056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.
    Giasson BI; Ischiropoulos H; Lee VM; Trojanowski JQ
    Free Radic Biol Med; 2002 Jun; 32(12):1264-75. PubMed ID: 12057764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.
    Fão L; Mota SI; Rego AC
    Ageing Res Rev; 2019 Sep; 54():100942. PubMed ID: 31415806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of specific dopaminergic neuronal death in Parkinson's disease].
    Ogawa N; Asanuma M; Miyoshi K
    Nihon Rinsho; 2004 Sep; 62(9):1629-34. PubMed ID: 15462376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates.
    Collier TJ; Kanaan NM; Kordower JH
    Nat Rev Neurosci; 2011 Jun; 12(6):359-66. PubMed ID: 21587290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free radicals: important cause of pathologies refer to ageing.
    Venarucci D; Venarucci V; Vallese A; Battilà L; Casado A; De la Torre R; Lopez Fernandez ME
    Panminerva Med; 1999 Dec; 41(4):335-9. PubMed ID: 10705716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.
    Kumar A; Leinisch F; Kadiiska MB; Corbett J; Mason RP
    Mol Neurobiol; 2016 Jul; 53(5):2983-2994. PubMed ID: 25952542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
    Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
    Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Roles of metabolic compartmentalization by astrocytes and neurons in the pathophysiology and treatment of Parkinson's disease].
    Takahashi S; Seki M; Suzuki N
    Brain Nerve; 2013 Dec; 65(12):1497-508. PubMed ID: 24323934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron Redox Chemistry and Implications in the Parkinson's Disease Brain.
    Abeyawardhane DL; Lucas HR
    Oxid Med Cell Longev; 2019; 2019():4609702. PubMed ID: 31687080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue.
    Imaizumi Y; Okada Y; Akamatsu W; Koike M; Kuzumaki N; Hayakawa H; Nihira T; Kobayashi T; Ohyama M; Sato S; Takanashi M; Funayama M; Hirayama A; Soga T; Hishiki T; Suematsu M; Yagi T; Ito D; Kosakai A; Hayashi K; Shouji M; Nakanishi A; Suzuki N; Mizuno Y; Mizushima N; Amagai M; Uchiyama Y; Mochizuki H; Hattori N; Okano H
    Mol Brain; 2012 Oct; 5():35. PubMed ID: 23039195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.
    Jansen van Rensburg Z; Abrahams S; Bardien S; Kenyon C
    Mol Neurobiol; 2021 Nov; 58(11):5920-5936. PubMed ID: 34426907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells.
    Chau KY; Cooper JM; Schapira AH
    Neurochem Int; 2010 Nov; 57(5):525-9. PubMed ID: 20624440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aging and Parkinson's disease: Different sides of the same coin?
    Collier TJ; Kanaan NM; Kordower JH
    Mov Disord; 2017 Jul; 32(7):983-990. PubMed ID: 28520211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.